Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet activation in thrombotic disorders

A T Nurden1, C Bihour, L Macchi

  • 1URA 1464 CNRS, Hôpital Cardiologique, Pessac, France.

Nouvelle Revue Francaise D'Hematologie
|February 1, 1993
PubMed
Summary

Measuring platelet activation markers can detect circulating activated platelets in cardiovascular disease patients. However, their presence did not directly correlate with future thrombotic events in this study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

Nature communications·2025
Same author

Awake laparotomy: is locoregional anesthesia a functional option for major abdominal surgeries in the COVID-19 era?

European review for medical and pharmacological sciences·2020
Same author

Assessment of conversational pragmatics: A screening tool for pragmatic language impairment in a control population of children aged 6-12 years.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Professor Gustav Victor Rudolph Born (29 July 1921 - 16 April 2018).

Journal of thrombosis and haemostasis : JTH·2018
Same author

Peripartum bleeding management in a patient with CalDAG-GEFI deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Fondaparinux upregulates thrombomodulin and the endothelial protein C receptor during early-stage reperfusion in a rat model of myocardial infarction.

Thrombosis research·2016

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Medicine

Background:

  • Platelet activation pathways and surface glycoprotein markers (e.g., GMP-140, GP IIb-IIIa) are increasingly understood.
  • Translocation of intracellular membrane glycoproteins and activation-dependent epitopes on GP IIb-IIIa are key indicators of platelet activation.
  • Flow cytometry enables quantification of these markers for assessing platelet activation in patient populations.

Purpose of the Study:

  • To investigate the utility of measuring platelet activation epitopes for predicting thrombosis in acute cardiovascular disease.
  • To examine platelet activation markers in patients with severe burns, post-coronary angioplasty, and post-myocardial infarction treated with fibrinolysis.

Main Methods:

  • Utilized monoclonal antibodies to detect activation-dependent epitopes on platelet surface glycoproteins.

Related Experiment Videos

  • Employed flow cytometry to quantify epitope expression and estimate activated platelet levels.
  • Studied three distinct patient cohorts with increased risk of thrombosis and/or bleeding.

    • Main Results:

    • Activated platelets were detectable in the circulation of studied patients.
    • The level of detected activated platelets correlated with the severity of the underlying cardiovascular lesion.
    • A direct correlation between the presence of these markers and the occurrence of future pathological thrombotic events was not established.

    Conclusions:

    • While activated platelets are detectable and their levels reflect disease severity, current markers do not reliably predict future thrombotic events in acute cardiovascular disease.
    • Further research is needed to identify predictive markers for thrombosis in these high-risk patient groups.